New York City, NY -- (SBWIRE) -- 12/16/2013 -- StockMarketIntel.com issues a special report on the following stocks: Buka Ventures Inc (OTCMKTS:NNRX), Pan Global Corp (OTCMKTS:PGLO), Chromadex Corp (OTCMKTS:CDXC), Sigma Labs Inc (OTCMKTS:SGLB)
Buka Ventures Inc (OTCMKTS:NNRX) declined -8.89%, trading on 1.71 million shares, to end the trade at $0.410. The stock changed hands in a range of $0.38 to $0.45, bringing its market capitalization to about $20.93 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.12 and was moved to the maximum level of $1.48. Nutranomics, Inc. researches and develops nutritional food products. Its nutritional products include supplements for joint health, digestive enzymes, whole food multi-vitamin, antioxidants, pre and probiotic, immune support, hormone balance, stress/sleep, detox/cleanse, natural vitamin C, and natural antiviral.
Has NNRX Found The Bottom and Ready To Move Up? Find Out Here
Pan Global Corp (OTCMKTS:PGLO) declined -5.59%, to complete the trading session at $0.287, with a total volume of 423,858 shares. The stock, on average, trades on a volume of 2.65 million shares. It floated in a range of $0.26 to $0.30.Its market capitalization now moved to about $130.63 million. In the past 52 weeks, the share price has not declined below $0.20 and above $3.50. Pan Global, Corp. operates as a renewable energy technology and sustainable infrastructure company in the United States. It focuses on developing projects and technologies in environmentally sustainable energy and infrastructure markets.
Has PGLO Found The Bottom And Ready To Gain Momentum? Find Out Here
Chromadex Corp (OTCMKTS:CDXC) recorded a fall of -4.69% and was in a range of $1.12-$1.29 before closing at $1.22. The stock completed the day with a total volume of 503,166 shares, versus an average volume of 279,829 shares. The share price hit its 52-week low of $0.50 and $1.37 was the best price. ChromaDex Corporation, a natural products company, through its subsidiaries, discovers, acquires, develops, and commercializes proprietary-based ingredient technologies. The company utilizes its wholly-owned synergistic business units, including ingredient technologies, natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting.
Why Should Investors Buy CDXC After the Recent Fall? Just Go Here and Find Out
Sigma Labs Inc (OTCMKTS:SGLB) declined -4.21%, bringing its market capitalization around $113.78 million. The share price, after opening at $0.21, made a high of $0.22 and hovered above $0.20 to end the day at $0.205. The total number of shares that changed hands during the session was 1.66 million shares, as compared to average trading volume of 7.49 million shares. Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and R&D solutions. It also focuses on commercializing technologies and products in various industry sectors, such as in process quality assurance for manufacturing; aerospace and defense manufacturing; additive manufacturing; active protection systems for defending light armored vehicles; advanced materials for munitions; advanced materials for sporting goods; advanced manufacturing technologies; and dental implant and biomedical prosthetics technologies.
Will SGLB Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)